Megan Adediran: Creating Road to Clot to Close the Gap in Undiagnosed Bleeding Disorders in Nigeria
Megan Adediran, Executive Director of the Haemophilia Foundation of Nigeria, shared a post on LinkedIn:
“Global prevalence estimates suggest that tens of thousands of Nigerians may be living with undiagnosed bleeding disorders.
Many endure avoidable pain, disability, and loss simply because the right questions were never asked and the right tests were never done.
This gap is what led the Haemophilia Foundation of Nigeria to create Road to Clot.
Through Road to Clot, we take screening beyond hospital walls and into communities. Using mobile outreach, we assess bleeding history, carry out basic clotting tests, provide counselling, and link individuals and families to appropriate care.
Our aim is straightforward and urgent: to find people early, reduce preventable suffering, and build a clear pathway into care and reliable data for action.
We are calling on partners across government, healthcare, faith-based institutions, and civil society to stand with us. Awareness saves lives. Early diagnosis saves lives.
This is the path we have chosen.
This is the Road to Clot”
Stay updated on all scientific advances with Hemostasis Today.
-
May 24, 2026, 15:33Mohammed Zubair: AI-Driven Innovation in Stroke Diagnosis and Medical Imaging
-
May 24, 2026, 14:26Salome Mekhuzla: World Health Assembly Adopts Historic Global Resolution for Hemophilia and Bleeding Disorders
-
May 24, 2026, 13:10Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
-
May 24, 2026, 12:04Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
-
May 24, 2026, 11:50Peter Zdziarski: Making Rare Disease Research More Human
-
May 24, 2026, 11:39Bram Berkelmans: Donating with a View
-
May 24, 2026, 11:28Ratiporn Chinthammit: A Meaningful Exchange in aHUS and PNH Education
-
May 24, 2026, 11:17Mary Ann Sromoski: Transfusion Medicine and Patient Blood Management in Practice
-
May 24, 2026, 07:45Thierry Burnouf: Advances in Platelet Membrane-Coated Nanoparticles for Targeted Therapeutics and Regenerative Medicine